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Abstract
Background: RNase H is an endonuclease that hydrolyzes the RNA strand in RNA/DNA hybrids. Retroviral reverse
transcriptases harbor a C-terminal RNase H domain whose activity is essential for viral replication. The RNase H
degrades the viral genomic RNA after the first DNA strand is synthesized. Here, we report the biophysical and
enzymatic properties of the RNase H domain of prototype foamy virus (PFV) as an independently purified protein.
Sequence comparisons with other retroviral RNases H indicated that PFV RNase H harbors a basic protrusion,
including a basic loop and the so-called C-helix, which was suggested to be important for activity and substrate
binding and is absent in the RNase H domain of human immunodeficiency virus. So far, no structure of a retroviral
RNase H containing a C-helix is available.
Results: RNase H activity assays demonstrate that the PFV RNase H domain is active, although its activity is about
200-fold reduced as compared to the full length protease-reverse transcriptase enzyme. Fluorescence equilibrium
titrations with an RNA/DNA substrate revealed a KD for the RNase H domain in the low micromolar range which is
about 4000-fold higher than that of the full-length protease-reverse transcriptase enzyme. Analysis of the RNase H
cleavage pattern using a [
32P]-labeled substrate indicates that the independent RNase H domain cleaves the
substrate non-specifically. The purified RNase H domain exhibits a well defined three-dimensional structure in
solution which is stabilized in the presence of Mg
2+ ions.
Conclusions: Our data demonstrate that the independent PFV RNase H domain is structured and active. The
presence of the C-helix in PFV RNase H could be confirmed by assigning the protein backbone and calculating the
chemical shift index using NMR spectroscopy.
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Background
Retroviral reverse transcription describes the formation
of a double-stranded DNA using the single-stranded
viral RNA genome as a template. The process is cata-
lyzed by the viral reverse transcriptase which harbors a
polymerase and an RNase H domain.
In most retroviruses reverse transcription takes place
after the virus has entered the host cell. Spumaviruses,
or foamy viruses (FVs), belong to a subfamily of the ret-
roviridae and follow a distinct replication pattern unique
among retroviruses: (a) reverse transcription occurs pre-
dominantly in the virus producing cell (b) the pol-gene
coding for the viral enzymes is expressed from an
independently spliced mRNA and (c) the viral protease
is not cleaved off from the Pol precursor protein, lead-
ing to a mature protease-reverse transcriptase (PR-RT)
[1-5]. Thus the mature PR-RT of FVs harbors a pro-
tease, polymerase and RNase H domain, each possessing
a distinct enzymatic activity [4].
Retroviral RNases H are domains of the RT enzymes
and degrade the RNA strand of the RNA/DNA hybrid
which is formed in the first step of reverse transcription.
This catalytic activity is essential during reverse tran-
scription and leads to degradation of the genomic RNA
during synthesis of the first or so-called minus DNA
using the RNA as a template [6,7]. Mutations that inac-
tivate the RNase H prevent viral replication [8,9].
RNase H cleavage by retroviral RTs, though generally
not sequence specific, is also not devoid of any specifi-
city. Retroviral RNases H exhibit three types of RNA
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and internal. Specific cleavages are required during
reverse transcription, when the extended tRNA and
polypurine tract (PPT) primers, which are essential for
the initiation of minus and plus strand DNA synthesis,
have to be removed [10-17].
The isolated RNase H domain from human immuno-
deficiency virus type 1 (HIV-1) is enzymatically inactive
[18-21], whereas that from Moloney murine leukemia
virus (MoMLV) retains RNase H activity, albeit consid-
erably lower than that of the full length RT [22-24].
Sequence alignments and structural comparisons
revealed that MoMLV RNase H contains an additional
helix-loop structure, also named the “basic protrusion”,
which includes the so-called C-helix and a downstream
basic loop element [25-27]. This structural feature is
also present in the human and Escherichia coli (E. coli)
RNases H, both exist as independent proteins [28,29]. In
contrast, the positively charged basic protrusion, which
has been suggested to be important for substrate bind-
ing and/or activity [30-32], is missing in the HIV-1
RNase H domain, which is part of the RT enzyme [33].
Obviously, positively charged residues in the connection
domain fulfill this function in HIV-1 RT [34]. Deletion
of the putative C-helix of MoMLV RT results in replica-
tion defective viruses [30-32]. Similar to HIV-1 RNase
H, the RNase H of the bacterium Bacillus halodurans is
also devoid of a C-helix but still harbors a basic loop
element. This RNase H carries an additional N-terminal
extension, the so-called RNA-hybrid binding domain
(RHBD), which is important for substrate binding [35].
Here, we analyzed the enzymatic and structural prop-
erties of the RNase H domain of prototype FV (PFV)
because sequence alignments with other RNases H indi-
cated the presence of a C-helix. We wanted to receive
more information on this structural element, since HIV-
1 RNase H does not possess a C-helix and the published
s t r u c t u r eo fM o M L VR N a s eHc o u l do n l yb es o l v e d
using a deletion mutant lacking the C-helix [25],
whereas the crystal structure of the MoMLV RT in
complex with duplex DNA (PDB: 1RW3) did not permit
the building of a detailed model for the RNase H
domain, since the electron density of this domain was
not sufficiently well-ordered [36].
Activity assays and NMR spectroscopy of PFV RNase
H show that it exhibits enzymatic activity and a well-
defined three dimensional structure which harbors the
basic protrusion including the C-helix.
Results and Discussion
Purification of the PFV RNase H domain
Secondary structure predictions and sequence align-
ments of the PFV RNase H domain with the human and
E. coli RNases H as well as with the retroviral RNases H
from HIV-1 and MoMLV indicated the existence of a
C - h e l i x( F i g u r e1 )i nP F Va n dM o M L VR N a s e sH ,
whereas the RNase H of HIV-1 does not possess a C-
helix. The putative C-helix appears to be important for
t h ea c t i v i t yo ft h ef r e eR N a s eHd o m a i no fM o M L V
[25,30-32]. So far there is no structure of a retroviral
RNase H domain available that actually shows the C-
helix. Thus we wanted to prove experimentally by activ-
ity assays as well as NMR spectroscopy that PFV RNase
H harbors a C-helix.
To analyze the properties of the RNase H domain of
PFV we cloned the corresponding gene in an E. coli
expression vector. A publication by Pfrepper et al. [37]
suggested the existence of a cleavage site specific for FV
protease (PR) between the polymerase and RNase H
d o m a i n so fF VR Ta tt h es e q u e n c e
E
593GVF
596↓Y
597TDG
600. (The amino acid numbering
always refers to the full length PFV PR-RT protein).
In contrast, we have shown recently that the only clea-
vage in the Pol precursor protein takes place between
the RNase H and integrase domains. The mature PR-RT
of PFV is monomeric, and the RNase H is not cleaved
off [4,5]. Furthermore, secondary structure predictions
indicated that the putative cleavage site suggested by
Pfrepper et al. [37] is located in a b-strand (Figure 1).
Cleavage in a secondary structure element can have det-
rimental effects on the structural integrity of the protein
and thus this cleavage appears unlikely.
To find out more about the structure and function of
PFV RNase H, we expressed two different proteins, the
first one starting with Y
597TDG as suggested by Pfrep-
per et al. [37] as the N-terminal starting point of the
PFV RNase H domain and the second one starting six
amino acids further upstream with the sequence
Q
591YEGVFYTDG. This starting point was chosen, to
avoid cleavage in the predicted b-strand (Figure 1). The
two proteins were expressed with an N-terminal GB1
(immunoglobulin binding domain B1 of the streptococ-
cal protein G) solubility tag. The resulting fusion pro-
teins harbor a hexa-histidine tag at the N-terminus and
a tobacco etch virus (TEV) protease cleavage site
between GB1 and the corresponding RNase H domain.
However, the short version of the RNase H (Y
597-N
751)
proved unstable during expression and purification, indi-
cating that the putative first b-strand of the RNase H is
essential for the proper three-dimensional structure of
t h ep r o t e i n .O n l yt h el o n g e rR N a s eHv e r s i o n ,R N a s e
H-(Q
591-N
751), could be purified successfully and was
used for further analysis. After TEV cleavage and
removal of the GB1 tag, the purity of the RNase H-
(Q
591-N
751) was analyzed on a 19% SDS polyacrylamide
gel (Figure 2A). To determine whether the RNase H is
monomeric, we performed size exclusion chromatogra-
phy of RNase H-(Q
591-N
751)( F i g u r e2 B ) .T h e
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molecular mass of 19 kDa (theoretical value: 18 kDa),
demonstrating that the RNase H domain is monomeric.
Enzyme activity
Mutational analysis performed with MoMLV RNase H
indicated that the C-helix, which is part of the basic
protrusion (L
681-K
698 in PFV RNase H) is important for
the activity of the separate RNase H domain [22-24,38].
The putative basic protrusion of PFV RNase H harbors
five lysine residues (Figure 1).
Thus, we determined the cleavage activity of the free
RNase H-(Q
591-N
751)i nc o m p a r i s o nw i t ht h eR N a s eH
domain of the full length PFV PR-RT. We chose a fluor-
escence assay for the detection of the activities and
kinetic parameters since this assay proved to be very
sensitive (Figure 3A). Our results indicate that the free
PFV RNase H-(Q
591-N
751)d o m a i ni ss t i l la c t i v e ,
although to a much lesser extent than the full length
PR-RT. However, due to the low activity of PFV RNase
H-(Q
591-N
751)w ew e r eo n l ya b l et od e t e r m i n eK M and
vmax values for the full length PFV PR-RT (KM =5 . 3
nM (± 0.8), vmax =0 . 0 5p m o l / s( ±0 . 0 0 2 ) ) .E v e nw h e na
10-fold higher enzyme concentration of PFV RNase H-
(Q
591-N
751) (Figure 3A) was used, the activities were
more than 20 fold lower than for the PR-RT and
saturation could not be achieved. Therefore, neither the
fitting procedure nor graphical methods (Lineweaver-
Burk, Eadie-Hofstee, Hanes) for KM and vmax determina-
tion gave reliable results.
To further characterize the activity of RNase H-(Q
591-
N
751), a qualitative RNase H assay was performed with a
non-specific 20/27 mer DNA/RNA hybrid. The RNA
was labeled with [
32P] at the 5’ end to visualize the clea-
vage products. To obtain cleavage of the substrate, we
had to use almost 700 fold more RNase H-(Q
591-N
751)
than PR-RT (Figure 3B). This confirms our results with
the fluorescence assay described above, which also indi-
cated a lower activity of RNase H-(Q
591-N
751)( F i g u r e
3A). This is also reflected by the much higher dissocia-
tion constant (KD) determined (see below) for the
RNase H domain (Figure 4). The cleavage pattern of the
PR-RT confirms our previous data using a different sub-
strate [4]. The cleavages performed by PR-RT are direc-
ted by the 3’ end of the DNA primer, which binds to
the active site of the polymerase domain [10]. Conse-
quently, primary cleavage sites can be detected 16-19
nucleotides away from the 3’ OH primer terminus of
the hybrid. After 60 minutes, shorter cleavage products
can be found up to position -8. In contrast, due to the
lack of a polymerase active site, the cleavage pattern of
the RNase H domain is different. After just 10 minutes,
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Figure 1 Sequence alignment of different RNase H domains. The RNases H from human origin, E. coli, MoMLV RT and HIV-1 RT are shown in
comparison to the PFV RNase H. The numbers represent the amino acid numbers of the corresponding full length enzymes. The alignment was
performed with the program CLC Protein Workbench 5 (version 5.5.2.0). Arrows below in pink indicate the b-strands in MoMLV RNase H, the
corresponding amino acids in the other RNases H are highlighted by pink letters. Blue bars indicate a-helices in MoMLV RNase H, a-helical
stretches of the other RNases H are highlighted by blue letters. The C-helices are highlighted by bright cyan boxes. The active site residues are
highlighted in yellow.
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Page 3 of 11the RNase H domain exhibits a more equal distribution
of cleavage sites spanning from -2 to -19. Nevertheless,
certain sites appear to be preferred. Due to the high
enzyme concentration used, we cannot exclude that this
is derived from the binding of more than one enzyme
molecule to the substrate. Our results are comparable to
those obtained with the separate RNase H domain of
MoMLV, which is also relatively non-specific even when
A
B
Figure 2 Analysis of the purified PFV RNase H-(Q
591-N
751). (A)
SDS-PAGE of the purified PFV RNase H-(Q
591-N
751). PFV RNase H-(Q
591-
N
751) was purified via Ni-affinity chromatography, TEV cleavage
followed by a second Ni-affinity column to remove the 6His-GB1
tag. The flow through was concentrated and analyzed by a 19%
SDS-PAGE and Coomassie staining. Lane M, molecular weight
standard, the apparent molecular weights are indicated on the left.
The arrow indicates the band of PFV RNase H-(Q
591-N
751) of which
different amounts were loaded. (B) Size exclusion chromatography of
PFV RNase H-(Q
591-N
751) using an S75 HR 10/30 column. The run was
performed with 50 nmol of purified PFV RNase H-(Q
591-N
751)i n5 0
mM Na-phosphate buffer, pH 6.8, 100 mM NaCl and 0.5 mM DTT.
The inset shows the best fit to the data obtained for the molecular
masses of the standard proteins (open circles), which was used for
the determination of the molecular mass of PFV RNase H-(Q
591-N
751)
(closed circle).
A 
 
B 
 
Figure 3 RNase H activities of the full length PFV PR-RT and
RNase H-(Q
591-N
751). (A) Quantitative RNase H activity assay. Steady
state kinetic measurements of the velocity (pmol/s) of the RNase H
activities were performed with 1 nM PR-RT (closed circles) and 10
nM RNase H-(Q
591-N
751) (open circles), respectively, using increasing
amounts of a fluorescently labeled DNA/RNA hybrid substrate as
indicated. For PFV PR-RT the following values were obtained: KM =
5.3 nM (± 0.8), vmax = 0.05 pmol/s (± 0.002). The values were
obtained by the fit program GraFit using the Michaelis-Menten
equation v = vmax [S]/(KM + [S]) for the fitting procedure. The curve
shows the best fit to the data. Due to its low activity, the kinetic
parameters for the RNase H domain could not be determined. (B)
Qualitative RNase H assay. The 20/27mer DNA/RNA primer/template
substrate is shown on top of the figure. The cleavage sites are
indicated by arrows in the sequence on top and at the
corresponding band on the gel. The first nucleotide of the RNA
hybridized to the 3’-OH nucleotide of the DNA strand is designated
-1. 240 nM of the substrate were incubated with 30 nM PFV PR-RT
or 20 μM of the RNase H domain for the times indicated on top of
the gel. Reaction products were separated on a 15% sequencing gel
and visualized by phosphoimaging.
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Page 4 of 11specific substrates, i.e. containing the polypurine tract
are used [23,24]
To get more information on the kinetic parameters,
we set out to determine the dissociation constant (KD)
for substrate binding. In the full length PR-RT enzyme,
binding of the RNase H domain is amplified by the
polymerase domain which also binds to the substrate
and, due to its larger size, covers a larger portion of it.
To analyze whether the higher RNase H activity of the
full length PR-RT can,at least in part, be explained by a
higher binding affinity of PR-RT, we performed fluores-
cence equilibrium titrations with a fluorescently labeled
DNA/RNA primer/template substrate. The KD value of
9.1 nM (± 1.7) we obtained for the full length PFV PR-
RT (Figure 4A) is comparable to previously published
results [4]. However, again due to the fact that we were
not able to reach saturation, the KD-value for the RNase
H domain could not be determined precisely and is
greater than 40 μM (Figure 4B) showing a binding affi-
nity which is about 4000-fold lower than that of PFV
PR-RT. These results imply a large contribution of the
polymerase domain to substrate binding. Nevertheless,
the KD-value gives a rough estimate of the KM-value,
due to the fact that KM =( k -1/k1)+( k 2/k1), or if k2 can
be neglected KM =k -1/k1 =K D, indicating that the KM
for the RNase H domain is greater than 40 μM.
NMR analyses
Proper folding of the RNase H domain was analyzed by
NMR spectroscopy using uniformly
15N-labeled protein.
The activity of retroviral RNases H has been shown to
be dependent on Mg
2+, therefore NMR-spectra in the
absence and presence of Mg
2+ ions were recorded (Fig-
ure 5). An NMR spectrum correlating resonance fre-
quencies of amide protons and directly bonded
15N-
labeled nitrogen atoms (2D [
1H-
15N] HSQC, heteronuc-
lear single quantum correlation) allows the individual
detection of peptide backbone amide signals. Thus, each
signal represents a single amino acid of the peptide
chain, and the spectrum serves as a fingerprint of the
folding state of a protein. Adoption of a defined struc-
ture increases the dispersion of signals of amide protons
in the HSQC spectrum to 6.9 - 9.7 ppm, relative to a
random coil structure, which only exhibits an amide
proton signal range from 7.8 - 8.7 ppm.
The spectra measured with the RNase H domain
reveal that already in the absence of Mg
2+ well-dispersed
signals (signal range: 6.9 - 9.7 ppm) typical for a protein
with a defined tertiary structure are obtained (Figure
5A). However, the number of signals is not sufficient for
a protein with 165 amino acids, and the signal intensi-
ties show significant differences. This is due to non-uni-
form NMR relaxation properties displaying a variety of
dynamic processes not typical for a well-folded stable
domain. In the presence of Mg
2+ the number of reso-
nances increased remarkably, and the signal intensities
show a more uniform distribution which is characteristic
for a folded globular domain of 18 kDa (Figure 5B).
These results indicate that for the structural integrity of
the RNase H Mg
2+ is essential. It has been shown for
other RNases H, that two Mg
2+ ions are bound in the
catalytic center and are important for catalysis of the
RNA cleavage by a two metal ion mechanism [29,39,40].
Although the presence of Mg
2+ is apparently not neces-
sary for substrate binding by RTs [41-43], the Mg
2+ ions
appear to stabilize the overall structure of the RNase H
domain and make the protein more rigid since the Mg
2+
ions are coordinated by three highly conserved aspartate
residues and one glutamate residue in RNases H of
known structure. In the case of PFV RNase H the corre-
sponding residues are D
599,E
646,D
669,D
740 (Figure 1).
A 
B 
Figure 4 Determination of KD-values by fluorescence
anisotropy measurements. 5 nM fluorescently labeled DNA/RNA
primer/template substrate was titrated with PR-RT (closed circles)
(A) or RNase H-(Q
591-N
751) (open circles) (B) as indicated. The fit of
the curve to the data (equation 1) resulted in a KD-value of 9.1 nM
(± 1.7) for the full length PFV PR-RT. The KD-value obtained for
RNase H-(Q
591-N
751) is greater than 40 μM.
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Page 5 of 11NMR data analysis of triple resonance experiments of
uniformly
15N,
13C labeled RNase H-(Q
591-N
751) allowed
the assignment of the backbone resonances for all resi-
dues except, D
607,N
639,N
692-K
695,Q
725-N
728,S
730,I
731,
E
734. The assigned [
1H,
15N] HSQC spectrum is
depicted in Figure 6A. Residues which constitute the C-
helix (E
680 -S
686), as determined by the chemical shift
index (CSI) method (see below), are marked by boxes.
The proline at position 682 is not visible in the HSQC
spectrum due to the lack of a backbone N-H bond.
To determine the secondary structure elements and to
prove the existence of the C-helix experimentally, we
compared the observed NMR resonance frequencies
with tabulated values found in random coil peptides by
the CSI method (Figure 6B). The systematic deviations
of backbone chemical shifts (resonance frequencies rela-
tive to reference standard) from random coil values in
folded proteins form a valuable basis for the determina-
tion of sequence specific secondary structures and allow
the experimental verification of postulated secondary
structure elements. Helical secondary structures result
in upfield chemical shift changes (lower resonance fre-
quencies, lower ppm-values) of the a-protons (HA;
negative CSI value) and downfield chemical shift
changes (higher resonance frequencies, higher ppm-
values) of the a- and carbonyl carbons (CA, CO; posi-
tive CSI value). b-strands exhibit the opposite direction
of chemical shift changes compared to a-helical second-
ary structures.
In the RNase H domain, five sequence stretches (G
594-
I
603,N
612-Y
623,N
631-I
635,V
664-T
668,I
716-E
721)s h o w
upfield chemical shifts of a- and carbonyl carbons and
downfield chemical shifts of their a-protons, relative to
random coil values and thus can be identified as b-
strands (Figure 6B). The five sequence regions A
642-
L
658,F
671-K
679,E
680-S
686,H
699-S
711 and T
733-G
746 exhi-
bit the opposite direction of chemical shift changes
compared to random coil values indicating the presence
of a-helical secondary structures. The resulting overall
sequence specific secondary structure resembles that of
t h eR N a s eHd o m a i no fM o M L V( F i g u r e6 B )a n di s
consistent with other RNase H domains (Figure 1). The
C-helix of PFV RNase H spans the a-helical region
from E
680-S
686 (Figure 6B).
In contrast, for MoMLV the C-helix was only pre-
dicted by sequence alignments and structure compari-
sons with other RNases H since no structure of the
wild-type MoMLV RNase H could be obtained. The
crystal structure of the MoMLV RNase H domain (PDB:
2HB5) could only be solved with a mutant protein lack-
ing the C-helix [25]; thus no precise information on the
orientation of the C-helix and its involvement in sub-
strate binding could be made. Here we show that the
solution structure analysis of PFV RNase H reveals the
C-helix and adjacent regions. This is the first structural
analysis of a retroviral RNase H where the C-helix can
be detected.
Conclusion
T h ed e t e c t i o no fa c t i v i t yw i t ht h ef r e eP F VR N a s eH
domain complements our NMR data which indicate that
the protein is properly folded and harbors the basic
A 
B 
Figure 5 Influence of Mg
2+ on the structure of PFV RNase H-
(Q
591-N
751).
1H-
15N-HSQC spectra of 45 μM PFV RNase H-(Q
591-N
751)
were recorded at 298 K with a Bruker DRX 700 MHz spectrometer in
50 mM Na-phosphate pH 6.8, 100 mM NaCl, 0.5 mM DTT, 10% D2O
in the absence (A) or presence (B) of 6 mM MgCl2.
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B 
Figure 6 NMR backbone assignment. (A) [
1H,
15N] spectrum of the uniformly
15N,
13C labeled PFV RNase H-(Q
591-N
751). Numbers refer to amino
acid positions of the corresponding residues in the full length PFV PR-RT. NH2 side chains are connected by lines, the tryptophan side chains
are marked by ‘sc’. Several amino acids of the C-helix are marked by boxes. (B) Secondary chemical shift indices for Ha,C a, CO nuclei, and the
consensus of PFV RNase H-(Q
591-N
751). Deduced b-strands are represented by arrows, and helical regions by cylinders. Precise amino acid
numbering of the secondary structure elements are given in the text.
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Page 7 of 11protrusion including the C-helix. Our results suggest
that similar to MoMLV the independent monomeric
P F VR N a s eHd o m a i ni sa c t i v ed u et ot h ep r e s e n c eo f
the basic protrusion.
Furthermore, the data obtained here with PFV RNase
H-(Q
591-N
751) together with previously published data
[4,5] provide additional evidence that argues against the
predicted PR cleavage between the polymerase and
RNase H domain taking place [37].
These data expand the knowledge obtained with free
MoMLV RNase H, which can also be expressed sepa-
rately as an active enzyme, but with lower activity and
less substrate specificity [22-24], and can now be used
for further structural analyses by NMR since it has not
been possible so far to obtain the structure of a retro-
viral RNase H domain harboring a C-helix.
Methods
Cloning, expression and protein purification
The gene coding for PFV RNase H starting either with
the codon for Y
597 or Q
591 was amplified by PCR with a
5’ primer including an NcoIs i t ea n da3 ’ primer with a
BamHI restriction site for further cloning. The fragment
was cloned into the vector pET-GB1a (G. Stier, EMBL,
Heidelberg, Germany) via NcoIa n dBamHI. The
expressed RNase H domains (ca. 18 kDa) were thereby
fused to the 56 amino acids long B1 domain of Strepto-
coccal protein G (GB1, 8740 Da). Both fusion proteins
(ca. 27 kDa) harbor a hexa-histidine tag at the N-termi-
nus and a tobacco etch virus (TEV) protease cleavage
site between the GB1 and RNase H domains. Due to the
NcoI cloning site, the cleaved RNase H variants habor
an N-terminal extension of four additional amino acids
(GAMG) upstream of the actual start of the RNase H
amino acid sequence.
Gene expression was done in E. coli Rosetta DE3
(Novagen) in Luria broth [44] in the presence of 34 μg/
ml chloramphenicol and 30 μg/ml kanamycin. For NMR
studies M9 minimal medium [44] with 1× MEM vitamin
solution (Gibco, Karlsruhe, Germany) supplemented
with 1.5 g/l (
15NH4)2SO4 (Cambridge Isotope Labora-
tories, Inc., Andover, MA, USA) and 4 g/l
13C-glucose
(Euriso-Top, GIF-SUR-YVETTE, France) as the sole
nitrogen and carbon sources were used. Cells were
grown at 37°C to an optical density at 600 nm of 0.8.
Expression was induced by adding 1 mM IPTG followed
by incubation at 16°C over night. Cells were lysed using
aM i c r o f l u i d i z e r( M F T IC o rporation, Newton, MA,
USA) in a buffer containing 50 mM Na-phosphate pH
6.8, 1 M NaCl, 10 mM imidazole, 0.5 mM dithiothreitol
(DTT).
The protein was purified by immobilized nickel affi-
nity chromatography (5 ml HisTrap HP column, GE
Healthcare, Munich, Germany) applying an imidazole
step gradient for elution. Fractions containing GB1-
RNase H were dialyzed against 50 mM Na-phosphate
buffer pH 6.8, 300 mM NaCl, 0.5 mM DTT and cleaved
with 1 mg TEV protease per 7 mg fusion protein for
21-24 h at 4°C. The TEV protease and the cleaved off
GB1 tag were removed by a second Ni-affinity chroma-
tography. The free PFV RNase H-(Q
591-N
751) was col-
lected in the flow through. For HSQC-analysis in the
presence of MgCl2 the purification was performed with
6 mM MgCl2 throughout the procedure.
Size exclusion chromatography of PFV RNase H-
(Q
591-N
751) and purification of PFV PR-RT was per-
formed as described previously [4,45].
Quantitative RNase H activity assay
RNase H activity was measured quantitatively to deter-
mine steady state kinetic parameters by a fluorescence
assay as described previously [4]. The RNA-strand of
the hybrid was fluorescently labeled at the 3’ end with
6-carboxy-fluorescein (6-FAM) (RNA-5’-CCGAUCGCU-
CUCCUGGUGAUCCUUUCC-6-FAM), whereas the
DNA primer harbored a dabcyl quencher at the 5’ end
(DNA-5’-Dabcyl-GGAAAGGATCACCAGGAGAG)
(biomers.net GmbH, Ulm Germany). To 1 nM of PFV
P R - R To r1 0n Mo fP F VR N a s eH - ( Q
591-N
751)i n c r e a s -
ing amounts of the RNA/DNA substrate were added as
indicated (Figure 3A), in a buffer containing 50 mM
Tris/HCl pH 8.0, 80 mM KCl, 6 mM MgCl2 and 0.5
mM DTT. An increase in fluorescence emission at 520
nm (excitation 495 nm) can be detected after cleavage
of the RNA in the hybrid, which leads to dissociation of
a small 6-FAM labeled RNA fragment from the dabcyl
quencher. Fluorescence was measured on a Fluorolog-
Tau-3 spectrofluorometer (HORIBA Jobin Yvon GmbH,
Unterhaching, Germany). Initial cleavage rates were cal-
culated using the linear slope of the reaction progress
curve where less than 5% of substrate was cleaved. KM
and vmax values and their standard errors were obtained
by fitting the data to the Michaelis-Menten equation
using the fitting program GraFit 5.0 (Erithacus
software).
Qualitative RNase H assay
The RNA template (5’-CCGCUUUCCCCUCUCCUG-
GUGAUCCUU) (biomers.net GmbH, Ulm Germany)
was purified on a denaturing 20% polyacrylamide/8 M
urea gel. Ca. 30 pmol of the purified RNA was 5’ end-
labeled with 30 μCi g[
32P]-ATP (Hartmann Analytic,
Braunschweig, Germany) and 20 U T4 polynucleotide
kinase (New England Biolabs, Frankfurt, Germany) as
described [43]. The DNA primer (5’-AGGATCACCAG-
GAGAGGGGA) (biomers.net GmbH, Ulm Germany)
was hybridized to the RNA using a 1.2 fold molar excess
of the DNA in 50 mM Tris/HCl, pH 7.0, 80 mM KCl by
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Page 8 of 11heating the sample to 90°C for 1 minute, followed by
transfer to a heating block at 70°C and slow cooling to
room temperature.
Qualitative RNase H reactions were performed at 25°C
in a total volume of 25 μl in 50 mM Tris/HCl, pH 7.0,
80 mM KCl, 6 mM MgCl2,0 . 5m MD T Tw i t h3 0n M
PR-RT or 20 μMR N a s eH - ( Q
591-N
751), respectively.
After preincubation of the sample for 5 min at 25°C,
reactions were started by the addition of 240 nM RNA/
DNA hybrid. Aliquots were taken after 10 min, 30 min
and 60 min and stopped by the addition of an equal
volume of urea loading buffer (50 mM EDTA, 0.1%
xylene cyanol, 0.1% bromophenol blue, 8 M urea in 1 ×
TBE (Tris/Borate/EDTA)). Cleavage products were sepa-
rated by denaturing gel electrophoresis using 15% polya-
crylamide/8 M urea gels. After drying of the gel, the
reaction products were visualized using a FLA 3000
phosphoimaging device (rayrest, Straubenhardt,
Germany)
Fluorescence anisotropy measurements
Fluorescence equilibrium titrations were performed with
the full length PR-RT and the RNase H domain employ-
ing a Fluorolog-Tau-3 spectrofluorometer (HORIBA
Jobin Yvon GmbH, Unterhaching, Germany) to deter-
mine the dissociation constant (KD)f o ra nR N A / D N A
template/primer substrate labeled with the fluorescent
dye DY647 as described previously [43]. For the PR-RT
a 24/40-mer DNA/RNA primer/template substrate
(DNA-5’-ATCACCAGGAGAGGGGAAAGCGGA;
RNA-5’-DY647-CUAAUUCCGCUUUCCCCUCUC-
CUGGUGAUCCUUUCCAUCC) (biomers.net GmbH,
Ulm, Germany) was used as described [43]. However,
for the RNase H domain a shorter 12/18-mer primer/
template was chosen to avoid binding of more than one
protein molecule to the hybrid region. The following
sequences were used for the 12mer DNA primer 5’-
ATCAGGTGTCGC and the fluorescently labeled 18mer
RNA template 5’-DY647-AUAUAUGCGACACCUGAU
(biomers.net GmbH, Ulm, Germany). Titrations were
performed at 25°C in 1 ml of buffer consisting of 50
mM Tris/HCl pH 8.0, 80 mM KCl, 10 mM EDTA and
0.5 mM DTT. Upon excitation of the substrate at 652
nm, emission can be detected at 673 nm. The slit widths
w e r es e ta t8n mf o rP R - R T ,a n da t7n m( e x c i t a t i o n )
and 6 nm (emission) for the RNase H-(Q
591-N
751)
domain. 5 nM of substrate were used for PR-RT and 50
nM for the RNase H-(Q
591-N
751), respectively. Figure 4
shows representative titration experiments. After equili-
bration of the sample for 3 minutes, at least six data
points with an integration time of 1 s were collected for
each titration point. The standard deviation for each
data point is represented by the error bars in Figure 4.
KD-values and their standard errors were calculated by
non-linear curve fitting of the anisotropy data to a two
component binding equation (equation 1) using the
software GraFit 5.0 (Erithacus software).
equation 1:
A=
AS +P· (R · AES · AS)
1 − P+R· P
with
P =
[ES]
[S]0
=
KD + [E]0 + [S]0 −

(KD + [E]0 + [S]0)2 − 4 · [S]0 · [E]0
2 · [S]0
where A = anisotropy measured; AS =a n i s o t r o p yo f
unbound substrate DNA/RNA; AES =a n i s o t r o p yo ft h e
complex; [ES] = concentration of enzyme/substrate com-
plex; [E]0 = total concentration of enzyme (PR-RT or
RNase H-(Q
591-N
751); [S]0 = total concentration of sub-
strate DNA/RNA; KD = dissociation constant; R = ratio of
fluorescence intensities of the bound and free substrate.
NMR analyses
1m Mu n i f o r m l y
15N labeled RNase H-(Q
591-N
751)w a s
analyzed in 5 mM Na-phosphate pH 6.8 or 7.0, 100 mM
NaCl, 0.5 mM DTT, 10% D2O (v/v) in the absence or
presence of 6 mM MgCl2. For NMR resonance assign-
ment standard double and triple resonance through-
bond correlation experiments [46,47] were recorded
using 1 mM
15N,
13C labeled RNase H-(Q
591-N
751), in 5
mM Na-phosphate pH 7.0, 100 mM NaCl, 6 mM
MgCl2, 0.5 mM DTT, 10% D2O (v/v) at 25°C on a Bru-
ker Avance 700 MHz spectrometer equipped with a
cryogenically cooled probe. In-house protocols were
used to process the NMR data and the program
NMRview were utilized for analysis (B.A. Johnson,
Merck, Whitehouse Station, NJ, USA).
Data deposition
The PFV RNase H-(Q
591-N
751) assignments have been
deposited in the BioMagResBank, accession number:
17745
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